Agenda. Jan Jones RN, MSN, IgCN, President of IgNS IgNS Leadership Team. 8:30 AM 10:00 AM PLENARY SESSION 1 (1.5 CE) Regency A

Size: px

Start display at page:

Download "Agenda. Jan Jones RN, MSN, IgCN, President of IgNS IgNS Leadership Team. 8:30 AM 10:00 AM PLENARY SESSION 1 (1.5 CE) Regency A"

Cassandra Townsend
8 years ago
Views:

1 Agenda Friday, September 18, :00 AM 8:30 AM OPENING REMARKS (0.5 CE) Regency A The State Of IgNS Jan Jones RN, MSN, IgCN, President of IgNS IgNS Leadership Team 8:30 AM 10:00 AM PLENARY SESSION 1 (1.5 CE) Regency A Ig Industry: Manufacturing, Legislative, and Clinical Updates Julie A. Birkofer, VP North America, PPTA Kendall Van Pool, VP of Legislative Affairs, National Home Infusion Association Ashar Hasan, RPh, MBA, Chief Business Development Officer, Medmonk, Inc. Neil Ross, IgNS Patient Advocacy Committee, Director, Patient Advocacy and Support 10:00 AM 10:30 AM BREAK & EXHIBITS Columbia ABC 10:30 AM 11:00 AM BAXALTA Product Theater Presentation Regency A Initiating and Managing the Infusion (No CE) Susan Kondik, RN, IgCN, CRNI, BSN 11:00 AM - 12:30 PM PLENARY SESSION 2 (1.5 CE) Regency A Ig Therapy in Dermatology: Acute Blistering Mucocutaneous Disorders Sergei Grando, MD PhD, Professor of Dermatology, University of California Irvine Kenny Metcalf, Patient s Experience 12:30 PM 2:00 PM LUNCH & EXHIBITS Columbia ABC 2:00 PM - 2:30 PM CSL BEHRING Product Theater Presentation (No CE) Regency A Expect More From Your Ig Therapy: Partnering with patients to offer a lifetime of possibilities

5 CE) Regency A Ig Industry: Manufacturing, Legislative, and Clinical Updates Julie A.

2 Debbie Manning, RN, BSN, IgCN 2:30 PM 3:30 PM Breakout Sessions (1 CE) Session 101 Individualizing Therapy Patients, Products and Routes Management of patients transitioning from IVIG to SCIG M. Cathy Dragisity RN, CRNI, IgCN, Coram/CVS Health Session 102 Autoimmunity and Immunoglobulin Mechanism of Action Alison Walsh MD, Associate Clinical Professor of Neurology, Jefferson University Session 103 Immune System and Primary Immunodeficiency Everglades Joseph A. Bellanti, MD Professor of Pediatrics and Microbiology-Immunology Georgetown University Medical Center Session 104 Creating Patient Education Tools to Maximize Comprehension and Independence Kathy Puglise, MSN/ED, BSN, RN, CRNI Clinical Manager, Home Infusion Smiths Medical 3:30 PM 4:00 PM BREAK & EXHIBITS Columbia ABC 4:00 PM 5:00 PM Breakout Sessions (1.0 CE) Session 105 Individualizing Therapy Patients, Products and Routes M. Cathy Dragisity RN, CRNI, IgCN, Coram/CVS Health Session 106 Autoimmunity and Immunoglobulin Mechanism of Action Alison Walsh MD, Associate Clinical Professor of Neurology, Jefferson University Session 107 Immune System and Primary Immunodeficiency Everglades Joseph A. Bellanti, MD Professor of Pediatrics and Microbiology-Immunology Georgetown University Medical Center Session 108 Creating Patient Education Tools to Maximize Comprehension and Independence Kathy Puglise, MSN/ED, BSN, RN, CRNI Clinical Manager, Home Infusion Smiths Medical 5:00 PM 6:30 PM Poster Session & Reception Lexington/Bunker Hill Supported By Home Solutions

Session 103 Immune System and Primary Immunodeficiency Everglades Joseph A.

3 Saturday, September 19, :00 AM - 9:00 AM BAXALTA BREAKFAST SYMPOSIUM (No CE) Regency A Patient-Centered Immunoglobulin Treatment in Patients With Primary Immunodeficiency: A Collaborative Approach Jan Ellen Jones, RN, MSN, IgCN (Chair/Moderator) Raffi Tachdjian, MD, MPH Amy E. Clarke, RN, IgCN Leslie J. Vaughan, RPh 9:00 AM - 10:30 AM PLENARY SESSION 3 (1.5 CE) Regency A Immune Globulin Treatment of Cytopenias and Vascular Disorders Michael D. Tarantino MD, Medical Director & President The Bleeding and Clotting Disorders Institute Professor of Pediatrics and Medicine, University of Illinois College of Medicine-Peoria 10:30 AM - 11:00 AM BREAK & EXHIBITS Columbia ABC 11:00 AM - 11:30 AM GRIFOLS PRODUCT THEATER PRESENTATION (No CE) Regency A Help Patients Choose IV or sub-q Elena E. Perez, MD, PhD, FAAI Maria C. Rodriguez, R.N., BSN 11:30 AM - 1:00 PM PLENARY SESSION 4 (1.5 CE) Regency A The Role of Immunoglobulin in Solid Organ Transplantation Jane Colona RN, CCTC, Director of Clinical Transplant Programs, BiologicTx 1:00 PM - 2:30 PM LUNCH & EXHIBITS Columbia ABC 2:30 PM - 3:00 PM BPL PRODUCT THEATER PRESENTATION (No CE) Regency A The role of 5% IVIG in the treatment of PI Kavita Aggarwal, PharmD 3:00 PM - 4:00 PM Breakout Sessions (1.0 CE) Session 201 Establishing Immunoglobulin Competency for Pharmacists Leslie Vaughan, RPh Senior Vice President, Clinical Programs, Nufactor Alan Huber, PharmD, MBA, IgNS Steering Committee Lisa Betts, PharmD, IgNS Steering Committee; Ig Program Director, OptionCare Session 202 Establishing Immunoglobulin Competency for Nurses

5 CE) Regency A Immune Globulin Treatment of Cytopenias and Vascular Disorders Michael D.

4 LouAnne Epperson, MSN, RN, IgCN, Manager Nursing Education, Infusion, Coram/CVS Jan Jones, MSN, RN, IgCN, Director of Nursing, Biofusion Session 203 Management of Adverse Reactions with IVIG and SCIG Tom Schleis, MS RPh, IgNS Editor-In-Chief; President Schleis Professional Services 4:00 PM - 4:30 PM BREAK & EXHIBITS Columbia ABC 4:30 PM - 5:30 PM Session 204 Establishing Immunoglobulin Competency for Pharmacists Leslie Vaughan, RPh Senior Vice President, Clinical Programs, Nufactor Alan Huber, PharmD, MBA Lisa Betts, PharmD, IgNS Steering Committee; Ig Program Director, OptionCare Session 205 Establishing Immunoglobulin Competency for Nurses LouAnne Epperson, MSN, RN, IgCN, Manager Nursing Education, Infusion, Coram/CVS Jan Jones, MSN, RN, IgCN, Director of Nursing, Biofusion Session 206 Management of Adverse Reactions with IVIG and SCIG Tom Schleis, MS RPh, IgNS Editor-In-Chief; President, Schleis Professional Services

for Pharmacists Leslie Vaughan, RPh Senior Vice President, Clinical Programs, Nufactor Alan Huber, PharmD, MBA Lisa Betts, PharmD, IgNS Steering Committee; Ig Program Director, OptionCare Session 205

5 Sunday, September 20, :00 AM 8:30AM INVITED GUEST LECTURE BREAKFAST SYMPOSIUM Regency A "The Breadth of Pharmacogenomics: Drug Therapy and Related Implications" David Kisor PharmD. Professor and Chair, Department of Pharmaceutical Sciences Manchester University 8:30 AM 10:00 AM PLENARY SESSION 5 (1.5 CE) Regency A The Cross-Talk Between the Nervous system and the Immune System Theoharis Theoharides MS, PhD, MD, FAAAAI Professor of Pharmacology and Internal Medicine Department of Integrative Physiology and Pathobiology Tufts University School of Medicine Isaac Melamed MD, ImmunoE Health and Research Centers Itay Melamed MD, Neurosurgeon at Advanced Brain & Spine 10:00 AM 10:30 AM BREAK & EXHIBITS Columbia ABC 10:30 AM 11:30 AM PLENARY SESSION 6 (1.0 CE) Regency A Treating Primary Immunodeficiency with Secondary Autoimmune Manifestations Terry Harville MD PhD Medical Director, Special Immunology Laboratory University of Arkansas for Medical Sciences 11:30 PM -1:00 PM LUNCH & EXHIBITS Columbia ABC 1:00 PM 2:00 PM Breakout Sessions (1.0 CE) Section 301 CGD With Inflammatory Complications Alexandra Freeman, MD, National Institutes of Health Section 302 Hot s and Updates on Immunoglobulin Reimbursement and Access Linda Payne, RN, President Reimbursement Concepts Dominick Spatafora, President Neuropathy Action Foundation (NAF) Kendall Van Pool, VP of Legislative Affairs, National Home Infusion Association Session 303 Quality of Life Assessments for Patients on Immunoglobulin Therapy Sean M Kearns Ph.D, Advisor, Registry Program, Coram/CVS Health

5 CE) Regency A The Cross-Talk Between the Nervous system and the Immune System Theoharis Theoharides MS, PhD, MD, FAAAAI Professor of Pharmacology and Internal Medicine Department of Integrative

6 2:00 3:00 PM Section 304 CGD With Inflammatory Complications Alexandra Freeman, MD, National Institutes of Health Section 305 Hot s and Updates on Immunoglobulin Reimbursement and Access Linda Payne, RN, President Reimbursement Concepts Dominick Spatafora, President Neuropathy Action Foundation (NAF) Kendall Van Pool, VP of Legislative Affairs, National Home Infusion Association Session 306 Quality of Life Assessments for Patients on Immunoglobulin Therapy Sean M Kearns Ph.D, Advisor, Registry Program, Coram/CVS Health

President Neuropathy Action Foundation (NAF) Kendall Van Pool, VP of Legislative Affairs, National Home Infusion Association

7 Ig Academy: Ig Certified Nurse Examination Preparation Course (4.75 CE) Agenda Sunday, September 20, 2015: Lexington/Concord/Bunker Hill Separate Registration Required 10:15 am 10:30 am Opening Remarks IgCN Examination Overview Jan E Jones, RN, MSN, IgCN Kelly Bertolazzi, RN, MSN, IgCN 10:30 am 11:30 am Overview of Immunoglobulin Products Tom Schleis, MS, RPh 11:30 am 12:00 am Patient Advocacy and Resources Becky Gamez, RN, BSN, IgCN, CNO 12:00 pm 1:30 pm Lunch and Exhibits 1:30 pm 3:00 pm Overview of Disorders Treated with Ig Carla Duff, CPNP-PC, MSN, CCRP, IgCN Becky Gamez, RN, BSN, IgCN, CNO Jane Kirmse, MS, APRN, CNS, IgCN 3:00 pm 3:45 pm IVIG Administration and Management Linda Schneider, RN, BSN, CPN, IgCN Kathy Puglise, MSN/ED, BSN, RN, CRNI 3:45 pm 4:30 pm SCIG Administration and Management 4:30 pm Adjourn Jeanette Scott, RN, BSN Susan Kondik, RN, IgCN, CRNI, BSN

Bertolazzi, RN, MSN, IgCN 10:30 am 11:30 am Overview of Immunoglobulin Products Tom Schleis, MS, RPh 11:30 am 12:00 am Patient Advocacy and Resources Becky Gamez, RN, BSN, IgCN, CNO 12:00 pm 1:30 pm

September 18-20, 2015

Advancing Ig Nursing and Pharmacy Practice this program book has been sponsored by September 18-20, 2015 Hyatt Regency Capitol Hill Washington, DC Welcome Dear Colleagues, IgNS Committees and Advisory